Article Versions Notes

Clerico M, Dogliotti I, Ghione P, Zilioli VR, Merli F, Botto B, Al Essa W, Battaglini M, Grimaldi D, Cervi L, et al. HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience. Journal of Personalized Medicine. 2022; 12(2):285. https://doi.org/10.3390/jpm12020285

Clerico, Michele, Irene Dogliotti, Paola Ghione, Vittorio Ruggero Zilioli, Francesco Merli, Barbara Botto, Wael Al Essa, Marcella Battaglini, Daniele Grimaldi, Loretta Cervi, and et al. 2022. "HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience" Journal of Personalized Medicine 12, no. 2: 285. https://doi.org/10.3390/jpm12020285

Clerico, M., Dogliotti, I., Ghione, P., Zilioli, V. R., Merli, F., Botto, B., Al Essa, W., Battaglini, M., Grimaldi, D., Cervi, L., Ragaini, S., Ferrero, S., Peri, V., De Luca, G., Marzano, A., & Cavallo, F. (2022). HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience. Journal of Personalized Medicine, 12(2), 285. https://doi.org/10.3390/jpm12020285